Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
33,560
archived clinical trials in
Neurology

Dysport® Adult Lower Limb Spasticity Follow-on Study
A Phase III, Prospective, Multicentre, Open Label, Extension Study, to Assess the Long Term Safety and Efficacy of Repeated Treatment of Dysport® Intramuscular Injection in the Treatment of Lower Limb Spasticity in Adult Subjects With Spastic Hemiparesis Due to Stroke or Traumatic Brain Injury
Status: Enrolling
Updated:  11/8/2017
mi
from
Chapel Hill, NC
Dysport® Adult Lower Limb Spasticity Follow-on Study
A Phase III, Prospective, Multicentre, Open Label, Extension Study, to Assess the Long Term Safety and Efficacy of Repeated Treatment of Dysport® Intramuscular Injection in the Treatment of Lower Limb Spasticity in Adult Subjects With Spastic Hemiparesis Due to Stroke or Traumatic Brain Injury
Status: Enrolling
Updated: 11/8/2017
University of North Carolina at Chapel Hill
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Dysport® Adult Lower Limb Spasticity Follow-on Study
A Phase III, Prospective, Multicentre, Open Label, Extension Study, to Assess the Long Term Safety and Efficacy of Repeated Treatment of Dysport® Intramuscular Injection in the Treatment of Lower Limb Spasticity in Adult Subjects With Spastic Hemiparesis Due to Stroke or Traumatic Brain Injury
Status: Enrolling
Updated:  11/8/2017
mi
from
Elkins Park, PA
Dysport® Adult Lower Limb Spasticity Follow-on Study
A Phase III, Prospective, Multicentre, Open Label, Extension Study, to Assess the Long Term Safety and Efficacy of Repeated Treatment of Dysport® Intramuscular Injection in the Treatment of Lower Limb Spasticity in Adult Subjects With Spastic Hemiparesis Due to Stroke or Traumatic Brain Injury
Status: Enrolling
Updated: 11/8/2017
Moss Rehab & Albert Einstein
mi
from
Elkins Park, PA
Click here to add this to my saved trials
Dysport® Adult Lower Limb Spasticity Follow-on Study
A Phase III, Prospective, Multicentre, Open Label, Extension Study, to Assess the Long Term Safety and Efficacy of Repeated Treatment of Dysport® Intramuscular Injection in the Treatment of Lower Limb Spasticity in Adult Subjects With Spastic Hemiparesis Due to Stroke or Traumatic Brain Injury
Status: Enrolling
Updated:  11/8/2017
mi
from
Nashville, TN
Dysport® Adult Lower Limb Spasticity Follow-on Study
A Phase III, Prospective, Multicentre, Open Label, Extension Study, to Assess the Long Term Safety and Efficacy of Repeated Treatment of Dysport® Intramuscular Injection in the Treatment of Lower Limb Spasticity in Adult Subjects With Spastic Hemiparesis Due to Stroke or Traumatic Brain Injury
Status: Enrolling
Updated: 11/8/2017
Vanderbilt University
mi
from
Nashville, TN
Click here to add this to my saved trials
Dysport® Adult Lower Limb Spasticity Follow-on Study
A Phase III, Prospective, Multicentre, Open Label, Extension Study, to Assess the Long Term Safety and Efficacy of Repeated Treatment of Dysport® Intramuscular Injection in the Treatment of Lower Limb Spasticity in Adult Subjects With Spastic Hemiparesis Due to Stroke or Traumatic Brain Injury
Status: Enrolling
Updated:  11/8/2017
mi
from
Dallas, TX
Dysport® Adult Lower Limb Spasticity Follow-on Study
A Phase III, Prospective, Multicentre, Open Label, Extension Study, to Assess the Long Term Safety and Efficacy of Repeated Treatment of Dysport® Intramuscular Injection in the Treatment of Lower Limb Spasticity in Adult Subjects With Spastic Hemiparesis Due to Stroke or Traumatic Brain Injury
Status: Enrolling
Updated: 11/8/2017
The University of Texas Southwestern Medical Center at Dalla
mi
from
Dallas, TX
Click here to add this to my saved trials
Dysport® Adult Lower Limb Spasticity Follow-on Study
A Phase III, Prospective, Multicentre, Open Label, Extension Study, to Assess the Long Term Safety and Efficacy of Repeated Treatment of Dysport® Intramuscular Injection in the Treatment of Lower Limb Spasticity in Adult Subjects With Spastic Hemiparesis Due to Stroke or Traumatic Brain Injury
Status: Enrolling
Updated:  11/8/2017
mi
from
Fort Worth, TX
Dysport® Adult Lower Limb Spasticity Follow-on Study
A Phase III, Prospective, Multicentre, Open Label, Extension Study, to Assess the Long Term Safety and Efficacy of Repeated Treatment of Dysport® Intramuscular Injection in the Treatment of Lower Limb Spasticity in Adult Subjects With Spastic Hemiparesis Due to Stroke or Traumatic Brain Injury
Status: Enrolling
Updated: 11/8/2017
University of North Texas HSC at Ben Hogan Center
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Dysport® Adult Lower Limb Spasticity Follow-on Study
A Phase III, Prospective, Multicentre, Open Label, Extension Study, to Assess the Long Term Safety and Efficacy of Repeated Treatment of Dysport® Intramuscular Injection in the Treatment of Lower Limb Spasticity in Adult Subjects With Spastic Hemiparesis Due to Stroke or Traumatic Brain Injury
Status: Enrolling
Updated:  11/8/2017
mi
from
Houston, TX
Dysport® Adult Lower Limb Spasticity Follow-on Study
A Phase III, Prospective, Multicentre, Open Label, Extension Study, to Assess the Long Term Safety and Efficacy of Repeated Treatment of Dysport® Intramuscular Injection in the Treatment of Lower Limb Spasticity in Adult Subjects With Spastic Hemiparesis Due to Stroke or Traumatic Brain Injury
Status: Enrolling
Updated: 11/8/2017
The University of Texas, Houston
mi
from
Houston, TX
Click here to add this to my saved trials
Dysport® Adult Lower Limb Spasticity Follow-on Study
A Phase III, Prospective, Multicentre, Open Label, Extension Study, to Assess the Long Term Safety and Efficacy of Repeated Treatment of Dysport® Intramuscular Injection in the Treatment of Lower Limb Spasticity in Adult Subjects With Spastic Hemiparesis Due to Stroke or Traumatic Brain Injury
Status: Enrolling
Updated:  11/8/2017
mi
from
Salt Lake City, UT
Dysport® Adult Lower Limb Spasticity Follow-on Study
A Phase III, Prospective, Multicentre, Open Label, Extension Study, to Assess the Long Term Safety and Efficacy of Repeated Treatment of Dysport® Intramuscular Injection in the Treatment of Lower Limb Spasticity in Adult Subjects With Spastic Hemiparesis Due to Stroke or Traumatic Brain Injury
Status: Enrolling
Updated: 11/8/2017
University of Utah School of Medicine
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Dysport® Adult Lower Limb Spasticity Follow-on Study
A Phase III, Prospective, Multicentre, Open Label, Extension Study, to Assess the Long Term Safety and Efficacy of Repeated Treatment of Dysport® Intramuscular Injection in the Treatment of Lower Limb Spasticity in Adult Subjects With Spastic Hemiparesis Due to Stroke or Traumatic Brain Injury
Status: Enrolling
Updated:  11/8/2017
mi
from
Kogarah,
Dysport® Adult Lower Limb Spasticity Follow-on Study
A Phase III, Prospective, Multicentre, Open Label, Extension Study, to Assess the Long Term Safety and Efficacy of Repeated Treatment of Dysport® Intramuscular Injection in the Treatment of Lower Limb Spasticity in Adult Subjects With Spastic Hemiparesis Due to Stroke or Traumatic Brain Injury
Status: Enrolling
Updated: 11/8/2017
St George Hospital
mi
from
Kogarah,
Click here to add this to my saved trials
Dysport® Adult Lower Limb Spasticity Follow-on Study
A Phase III, Prospective, Multicentre, Open Label, Extension Study, to Assess the Long Term Safety and Efficacy of Repeated Treatment of Dysport® Intramuscular Injection in the Treatment of Lower Limb Spasticity in Adult Subjects With Spastic Hemiparesis Due to Stroke or Traumatic Brain Injury
Status: Enrolling
Updated:  11/8/2017
mi
from
Winston-Salem, NC
Dysport® Adult Lower Limb Spasticity Follow-on Study
A Phase III, Prospective, Multicentre, Open Label, Extension Study, to Assess the Long Term Safety and Efficacy of Repeated Treatment of Dysport® Intramuscular Injection in the Treatment of Lower Limb Spasticity in Adult Subjects With Spastic Hemiparesis Due to Stroke or Traumatic Brain Injury
Status: Enrolling
Updated: 11/8/2017
Wake Forest University Baptist Medical Center
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Evaluation Phenobarbital as Adjunctive Therapy in Participants With Partial Onset Seizures
An International, Double-blind, Parallel-group, Placebo-controlled, Randomized Study: Evaluation of the Efficacy and Safety of Phenobarbital as Adjunctive Therapy in Participants (> or = 17 to 70 Years Old) With Partial Onset Seizures
Status: Enrolling
Updated:  11/9/2017
mi
from
Lexington, KY
Evaluation Phenobarbital as Adjunctive Therapy in Participants With Partial Onset Seizures
An International, Double-blind, Parallel-group, Placebo-controlled, Randomized Study: Evaluation of the Efficacy and Safety of Phenobarbital as Adjunctive Therapy in Participants (> or = 17 to 70 Years Old) With Partial Onset Seizures
Status: Enrolling
Updated: 11/9/2017
Bluegrass Epilepsy Research
mi
from
Lexington, KY
Click here to add this to my saved trials
Evaluation Phenobarbital as Adjunctive Therapy in Participants With Partial Onset Seizures
An International, Double-blind, Parallel-group, Placebo-controlled, Randomized Study: Evaluation of the Efficacy and Safety of Phenobarbital as Adjunctive Therapy in Participants (> or = 17 to 70 Years Old) With Partial Onset Seizures
Status: Enrolling
Updated:  11/9/2017
mi
from
Oklahoma City, OK
Evaluation Phenobarbital as Adjunctive Therapy in Participants With Partial Onset Seizures
An International, Double-blind, Parallel-group, Placebo-controlled, Randomized Study: Evaluation of the Efficacy and Safety of Phenobarbital as Adjunctive Therapy in Participants (> or = 17 to 70 Years Old) With Partial Onset Seizures
Status: Enrolling
Updated: 11/9/2017
Lynn Health Science Institute
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Evaluation Phenobarbital as Adjunctive Therapy in Participants With Partial Onset Seizures
An International, Double-blind, Parallel-group, Placebo-controlled, Randomized Study: Evaluation of the Efficacy and Safety of Phenobarbital as Adjunctive Therapy in Participants (> or = 17 to 70 Years Old) With Partial Onset Seizures
Status: Enrolling
Updated:  11/9/2017
mi
from
Rio Piedras,
Evaluation Phenobarbital as Adjunctive Therapy in Participants With Partial Onset Seizures
An International, Double-blind, Parallel-group, Placebo-controlled, Randomized Study: Evaluation of the Efficacy and Safety of Phenobarbital as Adjunctive Therapy in Participants (> or = 17 to 70 Years Old) With Partial Onset Seizures
Status: Enrolling
Updated: 11/9/2017
Centro Neurodiagnostico
mi
from
Rio Piedras,
Click here to add this to my saved trials
A Phase II Trial of Panobinostat and Lenalidomide in Patients With Relapsed or Refractory Hodgkin's Lymphoma
A Phase II Trial of Panobinostat and Lenalidomide in Patients With Relapsed or Refractory Hodgkin's Lymphoma
Status: Enrolling
Updated:  11/9/2017
mi
from
Columbus, OH
A Phase II Trial of Panobinostat and Lenalidomide in Patients With Relapsed or Refractory Hodgkin's Lymphoma
A Phase II Trial of Panobinostat and Lenalidomide in Patients With Relapsed or Refractory Hodgkin's Lymphoma
Status: Enrolling
Updated: 11/9/2017
Ohio State University Medical Center
mi
from
Columbus, OH
Click here to add this to my saved trials
A Phase II Trial of Panobinostat and Lenalidomide in Patients With Relapsed or Refractory Hodgkin's Lymphoma
A Phase II Trial of Panobinostat and Lenalidomide in Patients With Relapsed or Refractory Hodgkin's Lymphoma
Status: Enrolling
Updated:  11/9/2017
mi
from
Saint Louis, MO
A Phase II Trial of Panobinostat and Lenalidomide in Patients With Relapsed or Refractory Hodgkin's Lymphoma
A Phase II Trial of Panobinostat and Lenalidomide in Patients With Relapsed or Refractory Hodgkin's Lymphoma
Status: Enrolling
Updated: 11/9/2017
Washington University
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Imaging the Effect of Centrotemporal Spikes and Seizures on Language in Children
Imaging the Effect of Centrotemporal Spikes and Seizures on Language in Children
Status: Enrolling
Updated:  11/9/2017
mi
from
Cincinnati, OH
Imaging the Effect of Centrotemporal Spikes and Seizures on Language in Children
Imaging the Effect of Centrotemporal Spikes and Seizures on Language in Children
Status: Enrolling
Updated: 11/9/2017
Cincinnati Children's Hospital
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Occult Paroxysmal Atrial Fibrillation in Non-Cryptogenic Ischemic Stroke
Occult Paroxysmal Atrial Fibrillation in Non-Cryptogenic Ischemic Stroke
Status: Enrolling
Updated:  11/9/2017
mi
from
Manhasset, NY
Occult Paroxysmal Atrial Fibrillation in Non-Cryptogenic Ischemic Stroke
Occult Paroxysmal Atrial Fibrillation in Non-Cryptogenic Ischemic Stroke
Status: Enrolling
Updated: 11/9/2017
North Shore University Hospital
mi
from
Manhasset, NY
Click here to add this to my saved trials
Occult Paroxysmal Atrial Fibrillation in Non-Cryptogenic Ischemic Stroke
Occult Paroxysmal Atrial Fibrillation in Non-Cryptogenic Ischemic Stroke
Status: Enrolling
Updated:  11/9/2017
mi
from
New Hyde Park, NY
Occult Paroxysmal Atrial Fibrillation in Non-Cryptogenic Ischemic Stroke
Occult Paroxysmal Atrial Fibrillation in Non-Cryptogenic Ischemic Stroke
Status: Enrolling
Updated: 11/9/2017
Long Island Jewish Medical Center
mi
from
New Hyde Park, NY
Click here to add this to my saved trials
Computer Assisted Cognitive Rehabilitation for Persons With Multiple Sclerosis
Computer Assisted Cognitive Rehabilitation for Persons With Multiple Sclerosis
Status: Enrolling
Updated:  11/9/2017
mi
from
Austin, TX
Computer Assisted Cognitive Rehabilitation for Persons With Multiple Sclerosis
Computer Assisted Cognitive Rehabilitation for Persons With Multiple Sclerosis
Status: Enrolling
Updated: 11/9/2017
University of Texas at Austin
mi
from
Austin, TX
Click here to add this to my saved trials
Acetylcholinesterase Inhibitors to Improve Cognitive Function and Overall Rehabilitation After a Stroke
Donepezil/ Galantamine in the Treatment of Post-stroke Cognitively Impaired Rehabilitating Elderly
Status: Enrolling
Updated:  11/9/2017
mi
from
Pittsburgh, PA
Acetylcholinesterase Inhibitors to Improve Cognitive Function and Overall Rehabilitation After a Stroke
Donepezil/ Galantamine in the Treatment of Post-stroke Cognitively Impaired Rehabilitating Elderly
Status: Enrolling
Updated: 11/9/2017
University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Study Comparing Magnetic Seizure Therapy (MST) to Electroconvulsive Therapy (ECT) for Depression in Older Adults
Improving Outcomes in Geriatric Depression: Magnetic Seizure Therapy
Status: Enrolling
Updated:  11/13/2017
mi
from
New York, NY
Study Comparing Magnetic Seizure Therapy (MST) to Electroconvulsive Therapy (ECT) for Depression in Older Adults
Improving Outcomes in Geriatric Depression: Magnetic Seizure Therapy
Status: Enrolling
Updated: 11/13/2017
New York State Psychiatric Institute
mi
from
New York, NY
Click here to add this to my saved trials
Study of ITI-007 in Healthy Geriatric Volunteers and in Geriatric Patients With Dementia
A Randomized, Double-blind, Placebo-controlled, Multiple Oral Dose Escalation for Safety, Tolerability and Pharmacokinetics of ITI-007 in Healthy Geriatric Volunteers and in Geriatric Patients With Dementia.
Status: Enrolling
Updated:  11/13/2017
mi
from
Glendale, CA
Study of ITI-007 in Healthy Geriatric Volunteers and in Geriatric Patients With Dementia
A Randomized, Double-blind, Placebo-controlled, Multiple Oral Dose Escalation for Safety, Tolerability and Pharmacokinetics of ITI-007 in Healthy Geriatric Volunteers and in Geriatric Patients With Dementia.
Status: Enrolling
Updated: 11/13/2017
Clinical Research Facility
mi
from
Glendale, CA
Click here to add this to my saved trials
Cognitive ADHD Videogame Exploratory Study
A Study to Assess the Feasibility of EVO Gameplay to Engage Children With Attention Deficit Hyperactivity Disorder (ADHD) and to Evaluate Cognitive Interference in Children Ages 8 to 12 Years Old With ADHD Compared to Neuro-typical Children
Status: Enrolling
Updated:  11/14/2017
mi
from
Bradenton, FL
Cognitive ADHD Videogame Exploratory Study
A Study to Assess the Feasibility of EVO Gameplay to Engage Children With Attention Deficit Hyperactivity Disorder (ADHD) and to Evaluate Cognitive Interference in Children Ages 8 to 12 Years Old With ADHD Compared to Neuro-typical Children
Status: Enrolling
Updated: 11/14/2017
Florida Clinical Research Center, LLC
mi
from
Bradenton, FL
Click here to add this to my saved trials
Cognitive ADHD Videogame Exploratory Study
A Study to Assess the Feasibility of EVO Gameplay to Engage Children With Attention Deficit Hyperactivity Disorder (ADHD) and to Evaluate Cognitive Interference in Children Ages 8 to 12 Years Old With ADHD Compared to Neuro-typical Children
Status: Enrolling
Updated:  11/14/2017
mi
from
Durham, NC
Cognitive ADHD Videogame Exploratory Study
A Study to Assess the Feasibility of EVO Gameplay to Engage Children With Attention Deficit Hyperactivity Disorder (ADHD) and to Evaluate Cognitive Interference in Children Ages 8 to 12 Years Old With ADHD Compared to Neuro-typical Children
Status: Enrolling
Updated: 11/14/2017
Duke University
mi
from
Durham, NC
Click here to add this to my saved trials
A Pilot Study of Intermittent Calorie Restriction in Multiple Sclerosis
A Pilot Study of Intermittent Calorie Restriction in Multiple Sclerosis
Status: Enrolling
Updated:  11/14/2017
mi
from
Baltimore, MD
A Pilot Study of Intermittent Calorie Restriction in Multiple Sclerosis
A Pilot Study of Intermittent Calorie Restriction in Multiple Sclerosis
Status: Enrolling
Updated: 11/14/2017
Johns Hopkins University
mi
from
Baltimore, MD
Click here to add this to my saved trials
Optical Coherence Tomography (OCT) Trial in Multiple Sclerosis
A 3-year, Multi-center Study to Evaluate Optical Coherence Tomography as an Outcome Measure in Patients With Multiple Sclerosis
Status: Enrolling
Updated:  11/15/2017
mi
from
San Francisco, CA
Optical Coherence Tomography (OCT) Trial in Multiple Sclerosis
A 3-year, Multi-center Study to Evaluate Optical Coherence Tomography as an Outcome Measure in Patients With Multiple Sclerosis
Status: Enrolling
Updated: 11/15/2017
Novartis Investigative Site
mi
from
San Francisco, CA
Click here to add this to my saved trials
Optical Coherence Tomography (OCT) Trial in Multiple Sclerosis
A 3-year, Multi-center Study to Evaluate Optical Coherence Tomography as an Outcome Measure in Patients With Multiple Sclerosis
Status: Enrolling
Updated:  11/15/2017
mi
from
Torrance, CA
Optical Coherence Tomography (OCT) Trial in Multiple Sclerosis
A 3-year, Multi-center Study to Evaluate Optical Coherence Tomography as an Outcome Measure in Patients With Multiple Sclerosis
Status: Enrolling
Updated: 11/15/2017
Novartis Investigative Site
mi
from
Torrance, CA
Click here to add this to my saved trials
Optical Coherence Tomography (OCT) Trial in Multiple Sclerosis
A 3-year, Multi-center Study to Evaluate Optical Coherence Tomography as an Outcome Measure in Patients With Multiple Sclerosis
Status: Enrolling
Updated:  11/15/2017
mi
from
Iowa City, IA
Optical Coherence Tomography (OCT) Trial in Multiple Sclerosis
A 3-year, Multi-center Study to Evaluate Optical Coherence Tomography as an Outcome Measure in Patients With Multiple Sclerosis
Status: Enrolling
Updated: 11/15/2017
Novartis Investigator Site
mi
from
Iowa City, IA
Click here to add this to my saved trials
Optical Coherence Tomography (OCT) Trial in Multiple Sclerosis
A 3-year, Multi-center Study to Evaluate Optical Coherence Tomography as an Outcome Measure in Patients With Multiple Sclerosis
Status: Enrolling
Updated:  11/15/2017
mi
from
Baltimore, MD
Optical Coherence Tomography (OCT) Trial in Multiple Sclerosis
A 3-year, Multi-center Study to Evaluate Optical Coherence Tomography as an Outcome Measure in Patients With Multiple Sclerosis
Status: Enrolling
Updated: 11/15/2017
Novartis
mi
from
Baltimore, MD
Click here to add this to my saved trials
Optical Coherence Tomography (OCT) Trial in Multiple Sclerosis
A 3-year, Multi-center Study to Evaluate Optical Coherence Tomography as an Outcome Measure in Patients With Multiple Sclerosis
Status: Enrolling
Updated:  11/15/2017
mi
from
Philadelphia, PA
Optical Coherence Tomography (OCT) Trial in Multiple Sclerosis
A 3-year, Multi-center Study to Evaluate Optical Coherence Tomography as an Outcome Measure in Patients With Multiple Sclerosis
Status: Enrolling
Updated: 11/15/2017
Novartis Investigative Site
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Optical Coherence Tomography (OCT) Trial in Multiple Sclerosis
A 3-year, Multi-center Study to Evaluate Optical Coherence Tomography as an Outcome Measure in Patients With Multiple Sclerosis
Status: Enrolling
Updated:  11/15/2017
mi
from
Camperdown,
Optical Coherence Tomography (OCT) Trial in Multiple Sclerosis
A 3-year, Multi-center Study to Evaluate Optical Coherence Tomography as an Outcome Measure in Patients With Multiple Sclerosis
Status: Enrolling
Updated: 11/15/2017
Novartis Investigative Site
mi
from
Camperdown,
Click here to add this to my saved trials
Telehealth Coaching for Families of Children With Autism
Telehealth Coaching for Families of Children With Autism
Status: Enrolling
Updated:  11/15/2017
mi
from
Kansas City, KA
Telehealth Coaching for Families of Children With Autism
Telehealth Coaching for Families of Children With Autism
Status: Enrolling
Updated: 11/15/2017
Occupational Therapy Education
mi
from
Kansas City, KA
Click here to add this to my saved trials
Oral Immunotherapy for Childhood Egg Allergy
Oral Desensitization to Egg With Subsequent Induction of Tolerance for Egg-Allergic Children (CoFAR 3)
Status: Enrolling
Updated:  11/15/2017
mi
from
Little Rock, AR
Oral Immunotherapy for Childhood Egg Allergy
Oral Desensitization to Egg With Subsequent Induction of Tolerance for Egg-Allergic Children (CoFAR 3)
Status: Enrolling
Updated: 11/15/2017
University of Arkansas Children's Hospital Research Institute
mi
from
Little Rock, AR
Click here to add this to my saved trials
Oral Immunotherapy for Childhood Egg Allergy
Oral Desensitization to Egg With Subsequent Induction of Tolerance for Egg-Allergic Children (CoFAR 3)
Status: Enrolling
Updated:  11/15/2017
mi
from
Denver, CO
Oral Immunotherapy for Childhood Egg Allergy
Oral Desensitization to Egg With Subsequent Induction of Tolerance for Egg-Allergic Children (CoFAR 3)
Status: Enrolling
Updated: 11/15/2017
National Jewish Medical and Research Center
mi
from
Denver, CO
Click here to add this to my saved trials
Oral Immunotherapy for Childhood Egg Allergy
Oral Desensitization to Egg With Subsequent Induction of Tolerance for Egg-Allergic Children (CoFAR 3)
Status: Enrolling
Updated:  11/15/2017
mi
from
Baltimore, MD
Oral Immunotherapy for Childhood Egg Allergy
Oral Desensitization to Egg With Subsequent Induction of Tolerance for Egg-Allergic Children (CoFAR 3)
Status: Enrolling
Updated: 11/15/2017
Johns Hopkins University School of Medicine
mi
from
Baltimore, MD
Click here to add this to my saved trials
Oral Immunotherapy for Childhood Egg Allergy
Oral Desensitization to Egg With Subsequent Induction of Tolerance for Egg-Allergic Children (CoFAR 3)
Status: Enrolling
Updated:  11/15/2017
mi
from
New York, NY
Oral Immunotherapy for Childhood Egg Allergy
Oral Desensitization to Egg With Subsequent Induction of Tolerance for Egg-Allergic Children (CoFAR 3)
Status: Enrolling
Updated: 11/15/2017
Mount Sinai School of Medicine
mi
from
New York, NY
Click here to add this to my saved trials
Oral Immunotherapy for Childhood Egg Allergy
Oral Desensitization to Egg With Subsequent Induction of Tolerance for Egg-Allergic Children (CoFAR 3)
Status: Enrolling
Updated:  11/15/2017
mi
from
Chapel Hills, NC
Oral Immunotherapy for Childhood Egg Allergy
Oral Desensitization to Egg With Subsequent Induction of Tolerance for Egg-Allergic Children (CoFAR 3)
Status: Enrolling
Updated: 11/15/2017
University of North Carolina
mi
from
Chapel Hills, NC
Click here to add this to my saved trials
A Phase I Study of ABT-888 in Combination With Conventional Whole Brain Radiation Therapy (WBRT) in Cancer Patients With Brain Metastases
A Phase 1 Study Evaluating the Safety, Tolerability and Pharmacokinetics of ABT-888 in Combination With Whole Brain Radiation Therapy in Subjects With Brain Metastases
Status: Enrolling
Updated:  11/17/2017
mi
from
Madison, WI
A Phase I Study of ABT-888 in Combination With Conventional Whole Brain Radiation Therapy (WBRT) in Cancer Patients With Brain Metastases
A Phase 1 Study Evaluating the Safety, Tolerability and Pharmacokinetics of ABT-888 in Combination With Whole Brain Radiation Therapy in Subjects With Brain Metastases
Status: Enrolling
Updated: 11/17/2017
Clinical Research Facility
mi
from
Madison, WI
Click here to add this to my saved trials
A Phase I Study of ABT-888 in Combination With Conventional Whole Brain Radiation Therapy (WBRT) in Cancer Patients With Brain Metastases
A Phase 1 Study Evaluating the Safety, Tolerability and Pharmacokinetics of ABT-888 in Combination With Whole Brain Radiation Therapy in Subjects With Brain Metastases
Status: Enrolling
Updated:  11/17/2017
mi
from
Atlanta, GA
A Phase I Study of ABT-888 in Combination With Conventional Whole Brain Radiation Therapy (WBRT) in Cancer Patients With Brain Metastases
A Phase 1 Study Evaluating the Safety, Tolerability and Pharmacokinetics of ABT-888 in Combination With Whole Brain Radiation Therapy in Subjects With Brain Metastases
Status: Enrolling
Updated: 11/17/2017
Clinical Research Facility
mi
from
Atlanta, GA
Click here to add this to my saved trials
A Phase I Study of ABT-888 in Combination With Conventional Whole Brain Radiation Therapy (WBRT) in Cancer Patients With Brain Metastases
A Phase 1 Study Evaluating the Safety, Tolerability and Pharmacokinetics of ABT-888 in Combination With Whole Brain Radiation Therapy in Subjects With Brain Metastases
Status: Enrolling
Updated:  11/17/2017
mi
from
Chicago, IL
A Phase I Study of ABT-888 in Combination With Conventional Whole Brain Radiation Therapy (WBRT) in Cancer Patients With Brain Metastases
A Phase 1 Study Evaluating the Safety, Tolerability and Pharmacokinetics of ABT-888 in Combination With Whole Brain Radiation Therapy in Subjects With Brain Metastases
Status: Enrolling
Updated: 11/17/2017
Clinical Research Facility
mi
from
Chicago, IL
Click here to add this to my saved trials
A Phase I Study of ABT-888 in Combination With Conventional Whole Brain Radiation Therapy (WBRT) in Cancer Patients With Brain Metastases
A Phase 1 Study Evaluating the Safety, Tolerability and Pharmacokinetics of ABT-888 in Combination With Whole Brain Radiation Therapy in Subjects With Brain Metastases
Status: Enrolling
Updated:  11/17/2017
mi
from
Kansas City, KA
A Phase I Study of ABT-888 in Combination With Conventional Whole Brain Radiation Therapy (WBRT) in Cancer Patients With Brain Metastases
A Phase 1 Study Evaluating the Safety, Tolerability and Pharmacokinetics of ABT-888 in Combination With Whole Brain Radiation Therapy in Subjects With Brain Metastases
Status: Enrolling
Updated: 11/17/2017
Clinical Research Facility
mi
from
Kansas City, KA
Click here to add this to my saved trials
A Phase I Study of ABT-888 in Combination With Conventional Whole Brain Radiation Therapy (WBRT) in Cancer Patients With Brain Metastases
A Phase 1 Study Evaluating the Safety, Tolerability and Pharmacokinetics of ABT-888 in Combination With Whole Brain Radiation Therapy in Subjects With Brain Metastases
Status: Enrolling
Updated:  11/17/2017
mi
from
Baltimore, MD
A Phase I Study of ABT-888 in Combination With Conventional Whole Brain Radiation Therapy (WBRT) in Cancer Patients With Brain Metastases
A Phase 1 Study Evaluating the Safety, Tolerability and Pharmacokinetics of ABT-888 in Combination With Whole Brain Radiation Therapy in Subjects With Brain Metastases
Status: Enrolling
Updated: 11/17/2017
Clinical Research Facility
mi
from
Baltimore, MD
Click here to add this to my saved trials
A Phase I Study of ABT-888 in Combination With Conventional Whole Brain Radiation Therapy (WBRT) in Cancer Patients With Brain Metastases
A Phase 1 Study Evaluating the Safety, Tolerability and Pharmacokinetics of ABT-888 in Combination With Whole Brain Radiation Therapy in Subjects With Brain Metastases
Status: Enrolling
Updated:  11/17/2017
mi
from
Detroit, MI
A Phase I Study of ABT-888 in Combination With Conventional Whole Brain Radiation Therapy (WBRT) in Cancer Patients With Brain Metastases
A Phase 1 Study Evaluating the Safety, Tolerability and Pharmacokinetics of ABT-888 in Combination With Whole Brain Radiation Therapy in Subjects With Brain Metastases
Status: Enrolling
Updated: 11/17/2017
Clinical Research Facility
mi
from
Detroit, MI
Click here to add this to my saved trials
A Phase I Study of ABT-888 in Combination With Conventional Whole Brain Radiation Therapy (WBRT) in Cancer Patients With Brain Metastases
A Phase 1 Study Evaluating the Safety, Tolerability and Pharmacokinetics of ABT-888 in Combination With Whole Brain Radiation Therapy in Subjects With Brain Metastases
Status: Enrolling
Updated:  11/17/2017
mi
from
Philadelphia, PA
A Phase I Study of ABT-888 in Combination With Conventional Whole Brain Radiation Therapy (WBRT) in Cancer Patients With Brain Metastases
A Phase 1 Study Evaluating the Safety, Tolerability and Pharmacokinetics of ABT-888 in Combination With Whole Brain Radiation Therapy in Subjects With Brain Metastases
Status: Enrolling
Updated: 11/17/2017
Clinical Research Facility
mi
from
Philadelphia, PA
Click here to add this to my saved trials
A Phase I Study of ABT-888 in Combination With Conventional Whole Brain Radiation Therapy (WBRT) in Cancer Patients With Brain Metastases
A Phase 1 Study Evaluating the Safety, Tolerability and Pharmacokinetics of ABT-888 in Combination With Whole Brain Radiation Therapy in Subjects With Brain Metastases
Status: Enrolling
Updated:  11/17/2017
mi
from
Toronto,
A Phase I Study of ABT-888 in Combination With Conventional Whole Brain Radiation Therapy (WBRT) in Cancer Patients With Brain Metastases
A Phase 1 Study Evaluating the Safety, Tolerability and Pharmacokinetics of ABT-888 in Combination With Whole Brain Radiation Therapy in Subjects With Brain Metastases
Status: Enrolling
Updated: 11/17/2017
mi
from
Toronto,
Click here to add this to my saved trials
Trauma Survivors Outcomes and Support Study IV
Integrating Information Technology Advancements Into Early PTSD Interventions
Status: Enrolling
Updated:  11/17/2017
mi
from
Seattle, WA
Trauma Survivors Outcomes and Support Study IV
Integrating Information Technology Advancements Into Early PTSD Interventions
Status: Enrolling
Updated: 11/17/2017
Harborview Medical Center
mi
from
Seattle, WA
Click here to add this to my saved trials
Antihypertensive Treatment in Acute Cerebral Hemorrhage
Antihypertensive Treatment in Acute Cerebral Hemorrhage (ATACH)
Status: Enrolling
Updated:  11/17/2017
mi
from
Los Angeles, CA
Antihypertensive Treatment in Acute Cerebral Hemorrhage
Antihypertensive Treatment in Acute Cerebral Hemorrhage (ATACH)
Status: Enrolling
Updated: 11/17/2017
University of Southern California
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Antihypertensive Treatment in Acute Cerebral Hemorrhage
Antihypertensive Treatment in Acute Cerebral Hemorrhage (ATACH)
Status: Enrolling
Updated:  11/17/2017
mi
from
Kansas City, KA
Antihypertensive Treatment in Acute Cerebral Hemorrhage
Antihypertensive Treatment in Acute Cerebral Hemorrhage (ATACH)
Status: Enrolling
Updated: 11/17/2017
Kansas University Medical Center
mi
from
Kansas City, KA
Click here to add this to my saved trials
Antihypertensive Treatment in Acute Cerebral Hemorrhage
Antihypertensive Treatment in Acute Cerebral Hemorrhage (ATACH)
Status: Enrolling
Updated:  11/17/2017
mi
from
Kansas City, KA
Antihypertensive Treatment in Acute Cerebral Hemorrhage
Antihypertensive Treatment in Acute Cerebral Hemorrhage (ATACH)
Status: Enrolling
Updated: 11/17/2017
The University of Kansas School of Medicine, Wichita Via Christi Regional Medical Center
mi
from
Kansas City, KA
Click here to add this to my saved trials
Antihypertensive Treatment in Acute Cerebral Hemorrhage
Antihypertensive Treatment in Acute Cerebral Hemorrhage (ATACH)
Status: Enrolling
Updated:  11/17/2017
mi
from
Boston, MA
Antihypertensive Treatment in Acute Cerebral Hemorrhage
Antihypertensive Treatment in Acute Cerebral Hemorrhage (ATACH)
Status: Enrolling
Updated: 11/17/2017
Massachusetts General/Brigham Women's Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Antihypertensive Treatment in Acute Cerebral Hemorrhage
Antihypertensive Treatment in Acute Cerebral Hemorrhage (ATACH)
Status: Enrolling
Updated:  11/17/2017
mi
from
Minneapolis, MN
Antihypertensive Treatment in Acute Cerebral Hemorrhage
Antihypertensive Treatment in Acute Cerebral Hemorrhage (ATACH)
Status: Enrolling
Updated: 11/17/2017
Clinical Coordinating Center: University of Minnesota, Fairview Hospital
mi
from
Minneapolis, MN
Click here to add this to my saved trials